Relay Therapeutics, Inc.
RLAYNASDAQHealthcare● Active
$13.66
+$0.14(+1.04%)
Market Cap$2.4B
P/E Ratio—
52W High$17.47
52W Low$2.98
Relay Therapeutics, Inc.（RLAY）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · RLAY · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $15.36M | $10.01M | $25.55M | $1.38M | $3.03M |
| Cost of Revenue | $3.56M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $11.80M | $10.01M | $25.55M | $1.38M | $3.03M |
| Gross Margin %(computed) | 76.83% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $261.38M | $319.09M | $330.02M | $246.35M | $172.65M |
| G&A Expenses | $56.71M | $76.59M | $74.95M | $65.98M | $57.39M |
| Total Operating Expenses | $314.54M | $382.48M | $398.55M | $300.66M | $367.73M |
| Operating Income | ($302.74M) | ($372.47M) | ($373.00M) | ($299.27M) | ($364.70M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $27.04M | $34.75M | $31.05M | $8.79M | $0.83M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($276.48M) | ($337.71M) | ($341.97M) | ($290.51M) | ($363.87M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($276.48M) | ($337.71M) | ($341.97M) | ($290.51M) | ($363.87M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.61 | $-2.36 | $-2.79 | $-2.59 | $-3.82 |
| Wtd Avg Shares | 171.59M | 142.87M | 122.58M | 112.23M | 95.14M |
| EBITDA | ($272.92M) | ($380.21M) | ($374.15M) | ($306.82M) | ($223.08M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Relay Therapeutics, Inc.
关于Relay Therapeutics, Inc.（RLAY）损益表
Relay Therapeutics, Inc.（RLAY）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，RLAY实现营收$0.02B，毛利润$0.01B（毛利率76.83%），净利润($0.28B)（净利率-1800.58%）。
常见问题
RLAY · 4 问Relay Therapeutics, Inc.（RLAY）2025财年营收为$0.02B，同比up53.4%。
RLAY revenueRLAY salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08